BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 4769562)

  • 1. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral antibody response in volunteers given the live, highly attenuated "14" clone derived from Langat E5 virus.
    Mayer V
    Acta Virol; 1973 Jul; 17(4):367. PubMed ID: 4148224
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals].
    Korovina GI; Titova TS; Churnosov EV
    Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies.
    Bender A; Jäger G; Scheuerer W; Feddersen B; Kaiser R; Pfister HW
    J Neurol; 2004 Mar; 251(3):353-4. PubMed ID: 15015020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with killed vaccine against tick-borne encephalitis].
    Markvart K; Ostrovská A; Vlasimska H; Duniewicz M; Kulková H; Heinz F
    Cesk Epidemiol Mikrobiol Imunol; 1982 Nov; 31(6):321-8. PubMed ID: 6216960
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis.
    Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX
    J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of humoral immunity in post-vaccination resistance of mice to tick-borne encephalitis].
    Nikonova AN; Rozhkova LV; Sokolova ED
    Tr Inst Im Pastera; 1989; 65():84-90. PubMed ID: 2560848
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
    Vene S; Haglund M; Lundkvist A; Lindquist L; Forsgren M
    Vaccine; 2007 Jan; 25(2):366-72. PubMed ID: 16959384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update tick-borne encephalitis].
    Kaiser R
    MMW Fortschr Med; 2009 Mar; 151(11):38-9. PubMed ID: 19469203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination against tick-borne encephalitis in the Central Slovakia Region using a Soviet vaccine].
    Palanová A; Gresíková M; Sekeyová M; Pötheová A; Galvánek I; Januska J
    Cesk Epidemiol Mikrobiol Imunol; 1992 Jun; 41(2):69-77. PubMed ID: 1387048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a natural interferon inducer (RFf2) on the formation of vaccinal immunity to tick-borne encephalitis].
    Fomina AN; Nosik NN; Bukata LA; Davydova AA; Barinskiĭ NF
    Antibiotiki; 1979 Jan; 24(1):67-71. PubMed ID: 426497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against tick-borne encephalitis using the Soviet liquid inactivated vaccine].
    Plesník V; Januska J; Matuska J
    Cesk Epidemiol Mikrobiol Imunol; 1984 Nov; 33(6):338-45. PubMed ID: 6239701
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persistence of antibodies against tick-borne encephalitis (TBE) virus in man].
    Hubinger MG; Hofmann H; Krausler J
    Zentralbl Bakteriol Orig; 1970; 213(2):145-51. PubMed ID: 5469992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.